Chin B. Eap

Pharmacogenetics‐Based Population Pharmacokinetic Analysis of Efavirenz in HIV‐1‐Infected Individuals

A. Telenti, T. Buclin, J. Biollaz, 2009, Clinical pharmacology and therapeutics.

Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility

J. Cornuz, C. Eap, B. Oneda, 2011, Clinical pharmacology and therapeutics.

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone

D. Hochstrasser, Y. Daali, P. Dayer, 2010, British journal of pharmacology.

Adherence to Antidepressant Treatment: What the Doctor Thinks and What the Patient Says

F. Riquier,, C. Eap, S. Crettol, 2012, Pharmacopsychiatry.

β-Arrestin2 influences the response to methadone in opioid-dependent patients

M. Preisig, M. Bochud, C. Eap, 2011, The Pharmacogenomics Journal.